A drug which suppresses appetite will soon be available through the NHS.
Semaglutide, also known as Wegovy, has been hailed a “game changer” and is reportedly popular with celebrities in the USA. The drug, manufactured by Danish firm Novo Nordisk, is an appetite suppressant which is delivered via a weekly injection.
Patients inject themselves weekly with the drug, which mimics the hormone glucagon-like peptide-1 (GLP-1) that is released after eating. This makes people feel full, meaning they eat less and lose weight.
